Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01818
Species: Homo sapiens
Position : chr11:69419632-69420080
Year: 2022
Title: The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: renal cell carcinoma
PMID:  35676472
MONDO: MONDO:0005086
Tissue: kidney
Tissue Ontology ID: UBERON:0002113
Cell Source: 786-M1A
CVCL ID: CVCL_VR30
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; TF binding assay; Functional perturbation assay; Disease-variant functional analysis
High Throughput Method: Pooled in vivo CRISPRi screen; ATAC-seq; ChIP-seq
Low Throughput Method: CRISPRi; RT-qPCR; ChIP-qPCR
About Target Gene
Target gene : MYEOV
About TF
TF name : EPAS1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
EPAS1 HIF-2-alpha transcription factor network pid 34
EPAS1 Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha reactome 18
EPAS1 PTK6 Expression reactome 5
EPAS1 Regulation of gene expression by Hypoxia-inducible Factor reactome 10
EPAS1 Transcriptional regulation of pluripotent stem cells reactome 28
EPAS1 Pathways in cancer kegg 321
EPAS1 Renal cell carcinoma kegg 65
Enhancer Associated Network
Overlapping Enhancers (hg38) 3 found
Enhancer ID Position Tissue Cell Disease
E_01791 chr11:69419632-69420080 kidney malignant cell renal cell carcinoma
E_01815 chr11:69419632-69420080 bone element osteosarcoma cell osteosarcoma
E_01819 chr11:69419632-69420080 kidney malignant cell renal cell carcinoma
Expression of Target Genes for the Enhancer